Literature DB >> 22179768

Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.

J Schnorr1, M Taupitz, E A Schellenberger, C Warmuth, U L Fahlenkamp, S Wagner, N Kaufels, M Wagner.   

Abstract

PURPOSE: To compare citrate-coated very small superparamagnetic iron oxide particles (VSOP) with gadofosveset trisodium as blood pool contrast agents for cardiac magnetic resonance angiography (CMRA) in pigs.
MATERIALS AND METHODS: Animal experiments were approved by the responsible authority. 10 CMRA-like examinations were performed at 1.5 T after administration of VSOP (0.06  mmol Fe/kg; 5 examinations) and gadofosveset trisodium (0.03  mmol Gd/kg; 5 examinations). The CMRA protocol included ECG-gated inversion-recovery-prepared T1-weighted gradient echo imaging (IR-GRE; one slice) and ECG-gated inversion recovery prepared steady state free precession imaging (IR SSFP; one slice) before and 1, 3, 5, 10, 15, 20, 25, 30, 40, 50, and 60  min after injection. At each time point, three different inversion times (TI; 200  msec, 300  msec, and 400  msec) were applied. Contrast-to-noise ratios (CNR) between blood and myocardium were calculated and compared using mixed linear models.
RESULTS: No significant differences of CNR were found between IR-GRE and IR SSFP. At 3 and 5  min after contrast agent administration, VSOP showed a significantly higher CNR than gadofosveset trisodium when TI of 200  msec and 300 msec were applied (TI of 200  msec at 3 min: 8.2 ± 0.7 vs. 5.4 ± 0.7; TI of 200  msec at 5 min: 7.9 ± 0.7 vs. 3.5 ± 0.8; TI of 300  msec at 3  min: 11.7 ± 0.7 vs. 8.8 ± 0.8; TI of 300  msec at 5  min: 11.4 ± 0.7 vs. 8.0 ± 0.8; p < 0.05). Moreover, significant differences in favor of VSOP were found for all time points from 10 to 40  min irrespective of TI (p < 0.05).
CONCLUSION: VSOP has superior blood-pool properties compared to gadofosveset trisodium resulting in prolonged improvement of CNR on CMRA. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179768     DOI: 10.1055/s-0031-1281982

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  7 in total

1.  Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

Authors:  He Wei; Oliver T Bruns; Michael G Kaul; Eric C Hansen; Mariya Barch; Agata Wiśniowska; Ou Chen; Yue Chen; Nan Li; Satoshi Okada; Jose M Cordero; Markus Heine; Christian T Farrar; Daniel M Montana; Gerhard Adam; Harald Ittrich; Alan Jasanoff; Peter Nielsen; Moungi G Bawendi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

2.  Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents.

Authors:  He Wei; Agata Wiśniowska; Jingxuan Fan; Peter Harvey; Yuanyuan Li; Victoria Wu; Eric C Hansen; Juanye Zhang; Michael G Kaul; Abigail M Frey; Gerhard Adam; Anatoly I Frenkel; Moungi G Bawendi; Alan Jasanoff
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-19       Impact factor: 11.205

3.  Effect of iron oxide nanoparticles coating type on the relationship between nanoparticles concentration and signal intensity in inversion recovery T1-weighted MRI.

Authors:  Nahideh Gharehaghaji; Mahmood Nazarpoor; Hodaiseh Saharkhiz
Journal:  Med J Islam Repub Iran       Date:  2015-05-06

Review 4.  Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide.

Authors:  Shirjel R Alam; Colin Stirrat; Jennifer Richards; Saeed Mirsadraee; Scott I K Semple; George Tse; Peter Henriksen; David E Newby
Journal:  J Cardiovasc Magn Reson       Date:  2015-09-18       Impact factor: 5.364

5.  The Effect of Inversion Time on the Relationship Between Iron Oxide Nanoparticles Concentration and Signal Intensity in T1-Weighted MR Images.

Authors:  Hodaiseh Saharkhiz; Nahideh Gharehaghaji; Mahmood Nazarpoor; Asghar Mesbahi; Masoud Pourissa
Journal:  Iran J Radiol       Date:  2014-05-15       Impact factor: 0.212

6.  Labeling of mesenchymal stem cells for MRI with single-cell sensitivity.

Authors:  Angela Ariza de Schellenberger; Harald Kratz; Tracy D Farr; Norbert Löwa; Ralf Hauptmann; Susanne Wagner; Matthias Taupitz; Jörg Schnorr; Eyk A Schellenberger
Journal:  Int J Nanomedicine       Date:  2016-04-12

7.  Synthesis of europium-doped VSOP, customized enhancer solution and improved microscopy fluorescence methodology for unambiguous histological detection.

Authors:  Angela Ariza de Schellenberger; Ralf Hauptmann; Jason M Millward; Eyk Schellenberger; Yuske Kobayashi; Matthias Taupitz; Carmen Infante-Duarte; Jörg Schnorr; Susanne Wagner
Journal:  J Nanobiotechnology       Date:  2017-10-10       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.